Published Online
on April 16, 2007

A more recent version of this article appeared on May 1, 2007

This Article Full Text (PDF) All Versions of this Article: 115/17/2323    most recent CIRCULATIONAHA.107.691279v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleinschnitz, C. Articles by Stoll, G. Search for Related Content PubMed PubMed Citation Articles by Kleinschnitz, C. Articles by Stoll, G. Related Collections Animal models of human disease Aggregation Coagulation inhibitors Acute Cerebral Infarction Emergency treatment of Stroke Antiplatelets Platelets Related Article

Submitted on January 18, 2007
Accepted on March 9, 2007

Targeting Platelets in Acute Experimental Stroke. Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding

Christoph Kleinschnitz MD, Miroslava Pozgajova PhD, Mirko Pham MD, Martin Bendszus MD, Bernhard Nieswandt PhD, and Guido Stoll MD^*

From the Departments of Neurology (C.K., G.S.), Clinical Biochemistry and Pathophysiology (M. Pozgajova, B.N.), and Neuroradiology (M. Pham, M.B.) and the Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine (M. Pozgajova, B.N.), University of Würzburg, Würzburg, Germany.

^* To whom correspondence should be addressed. E-mail: stoll_g{at}klinik.uni-wuerzburg.de.

Background--Ischemic stroke is a frequent and serious disease with limited treatment options. Platelets can adhere to hypoxic cerebral endothelial cells by binding of their glycoprotein (GP) Ib receptor to von Willebrand factor. Exposure of subendothelial matrix proteins further facilitates firm attachment of platelets to the vessel wall by binding of collagen to their GPVI receptor. In the present study, we addressed the pathogenic role of GPIb, GPVI, and the aggregation receptor GPIIb/IIIa in experimental stroke in mice.

Methods and Results--Complete blockade of GPIb was achieved by intravenous injection of 100 µg Fab fragments of the monoclonal antibody p0p/B to mice undergoing 1 hour of transient middle cerebral artery occlusion. At 24 hours after transient middle cerebral artery occlusion, cerebral infarct volumes were assessed by 2,3,5-triphenyltetrazolium chloride staining. In mice treated with anti-GPIb Fab 1 hour before middle cerebral artery occlusion, ischemic lesions were reduced to 40% compared with controls (28.5±12.7 versus 73.9±17.4 mm³, respectively; P<0.001). Application of anti-GPIb Fab 1 hour after middle cerebral artery occlusion likewise reduced brain infarct volumes (24.5±7.7 mm³; P<0.001) and improved the neurological status. Similarly, depletion of GPVI significantly diminished the infarct volume but to a lesser extent (49.4±19.1 mm³; P<0.05). Importantly, the disruption of early steps of platelet activation was not accompanied by an increase in bleeding complications as revealed by serial magnetic resonance imaging. In contrast, blockade of the final common pathway of platelet aggregation with anti-GPIIb/IIIa F(ab)₂ fragments had no positive effect on stroke size and functional outcome but increased the incidence of intracerebral hemorrhage and mortality after transient middle cerebral artery occlusion in a dose-dependent manner.

Conclusions--Our data indicate that the selective blockade of key signaling pathways of platelet adhesion and aggregation has a different impact on stroke outcome and bleeding complications. Inhibition of early steps of platelet adhesion to the ischemic endothelium and the subendothelial matrix may offer a novel and safe treatment strategy in acute stroke.

Key words: cerebrovascular disorders • drug therapy • glycoproteins • intracerebral hemorrhage • magnetic resonance imaging • platelets • stroke

Related Article:

Issue Highlights
Circulation 2007 115: 2247. [Extract] [Full Text]

This article has been cited by other articles:

				A. Berna-Erro, A. Braun, R. Kraft, C. Kleinschnitz, M. K. Schuhmann, D. Stegner, T. Wultsch, J. Eilers, S. G. Meuth, G. Stoll, et al. STIM2 Regulates Capacitive Ca2+ Entry in Neurons and Plays a Key Role in Hypoxic Neuronal Cell Death Sci. Signal., October 20, 2009; 2(93): ra67 - ra67. [Abstract] [Full Text] [PDF]

				F. May, I. Hagedorn, I. Pleines, M. Bender, T. Vogtle, J. Eble, M. Elvers, and B. Nieswandt CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis Blood, October 15, 2009; 114(16): 3464 - 3472. [Abstract] [Full Text] [PDF]

				B.-Q. Zhao, A. K. Chauhan, M. Canault, I. S. Patten, J. J. Yang, M. Dockal, F. Scheiflinger, and D. D. Wagner von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke Blood, October 8, 2009; 114(15): 3329 - 3334. [Abstract] [Full Text] [PDF]

				J. Kisucka, A. K. Chauhan, B.-Q. Zhao, I. S. Patten, A. Yesilaltay, M. Krieger, and D. D. Wagner Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis Blood, June 4, 2009; 113(23): 6015 - 6022. [Abstract] [Full Text] [PDF]

				C. Kleinschnitz, S. F. De Meyer, T. Schwarz, M. Austinat, K. Vanhoorelbeke, B. Nieswandt, H. Deckmyn, and G. Stoll Deficiency of von Willebrand factor protects mice from ischemic stroke Blood, April 9, 2009; 113(15): 3600 - 3603. [Abstract] [Full Text] [PDF]

				A. Braun, D. Varga-Szabo, C. Kleinschnitz, I. Pleines, M. Bender, M. Austinat, M. Bosl, G. Stoll, and B. Nieswandt Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation Blood, February 26, 2009; 113(9): 2056 - 2063. [Abstract] [Full Text] [PDF]

				G. Stoll, C. Kleinschnitz, and B. Nieswandt Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment Blood, November 1, 2008; 112(9): 3555 - 3562. [Abstract] [Full Text] [PDF]

				D. Varga-Szabo, A. Braun, C. Kleinschnitz, M. Bender, I. Pleines, M. Pham, T. Renne, G. Stoll, and B. Nieswandt The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction J. Exp. Med., July 7, 2008; 205(7): 1583 - 1591. [Abstract] [Full Text] [PDF]

				B. Nieswandt How do platelets prevent bleeding? Blood, May 15, 2008; 111(10): 4835 - 4835. [Full Text] [PDF]

				T. Goerge, B. Ho-Tin-Noe, C. Carbo, C. Benarafa, E. Remold-O'Donnell, B.-Q. Zhao, S. M. Cifuni, and D. D. Wagner Inflammation induces hemorrhage in thrombocytopenia Blood, May 15, 2008; 111(10): 4958 - 4964. [Abstract] [Full Text] [PDF]

				C. Kleinschnitz, S. Braeuninger, M. Pham, M. Austinat, I. Nolte, T. Renne, B. Nieswandt, M. Bendszus, and G. Stoll Blocking of Platelets or Intrinsic Coagulation Pathway-Driven Thrombosis Does Not Prevent Cerebral Infarctions Induced by Photothrombosis Stroke, April 1, 2008; 39(4): 1262 - 1268. [Abstract] [Full Text] [PDF]

				D. Varga-Szabo, I. Pleines, and B. Nieswandt Cell Adhesion Mechanisms in Platelets Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 403 - 412. [Abstract] [Full Text] [PDF]